Recurrence of urinary tract infection in a primary care setting: Analysis of a 1-year follow-up of 179 women

Clinical Infectious Diseases

Volumn 22, Issue 1, 1996, Pages 91-99

  Ikäheimo, Risto ^a   Siitonen, Anja ^b   Heiskanen, Tarja ^b   Kärkkäinen, Ulla ^b   Kuosmanen, Pauli ^b   Lipponen, Pertti ^b   Mäkelä, P Helena ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AMPICILLIN; CEFALEXIN; CEFALOTIN; CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL; CINOXACIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MECILLINAM; NALIDIXIC ACID; NITROFURANTOIN; PIVMECILLINAM; POLYMYXIN B; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; VIRULENCE FACTOR;

ACUTE PYELONEPHRITIS; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL VIRULENCE; BACTERIURIA; CYSTITIS; DYSURIA; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT INFECTION; URINARY TRACT INFECTION;

EID: 0030034932     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.1.91     Document Type: Article

References (55)

1. Stamey TA. Pathogenesis and treatment of urinary tract infections. Baltimore: Williams & Wilkins, 1980.
2. Schaeffer AJ. Urinary tract infections in urology: a urologist's view of chronic bacteriuria. Infect Dis Clin North Am 1987;1(4):875-92.
3. Brauner A, Jacobson SH, Kühn I. Urinary Escherichia coli causing recurrent infections - a prospective follow-up of biochemical phenotypes. Clin Nephrol 1992;38:318-23.
4. Wold AE, Caugant DA, Lidin-Janson G, de Man P, Sranborg C. Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis 1992;165:46-52.
5. Jacobson SH, Källenius G, Lins L-E, Svenson SB. Symptomatic recurrent urinary tract infections in patients with renal scarring in relation to fecal colonization with P-fimbriated Escherichia coli. J Urol 1987;137: 693-6.
6. Väisänen V, Elo J, Tallgren LG, et al. Mannose-resistant hemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet 1981;2:1366-9.
7. Källenius G, Möllby R, Svenson SB, et al. Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet 1981;2:1369-72.
8. Väisänen-Rhen V, Elo J, Väisänen E, et al. P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun 1984;43:149-55.
9. Westerlund B, Siitonen A, Elo J, Williams PH, Korhonen TK, Mäkelä PH. Properties of Escherichia coli isolates from urinary tract infections in boys. J Infect Dis 1988;158:996-1002.
10. Latham RH, Stamm WE. Role of fimbriated Escherichia coli in urinary tract infections in adult women: correlation with localization studies. J Infect Dis 1984;149:835-40.
11. O'Hanley P, Low D, Romero I, et al. Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli. N Engl J Med 1985;313:414-20.
12. Jacobson SH, Lins LE, Svenson SB, Källenius G. P fimbriated Escherichia coli in adults with acute pyelonephritis [letter]. J Infect Dis 1985;152:426-7.
13. Johnson JR, Roberts PL, Stamm WE. P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patient's characteristics. J Infect Dis 1987;156:225-9.
14. Sandberg T, Kaijser B, Lidin-Janson G, et al. Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection. J Clin Microbiol 1988;26:1471-6.
15. Johnson JR, Moseley SL, Roberts PL, Stamm WE. Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 1988;56:405-12.
16. Otto G, Sandberg T, Marklund B-I, Ulleryd P, Svanborg C. Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with or without bacteremia. Clin Infect Dis 1993;17:448-56.
17. Brauner A, Leissner M, Wretlind B, Julander I, Svenson SB, Källenius G. Occurrence of P-fimbriated Escherichia coli in patients with bacteremia. Eur J Clin Microbiol 1985;4:566-9.
18. Domingue GJ, Roberts JA, Laucirica R, et al. Pathogenic significance of P-fimbriated Escherichia coli in urinary tract infections. J Urol 1985;133:983-9.
19. Gander RM, Thomas VL, Forland M. Mannose-resistant hemagglutination and P receptor recognition of uropathogenic Escherichia coli isolates from adult patients. J Infect Dis 1985;151:508-13.
20. Labigne-Roussel A, Falkow S. Distribution and degree of heterogeneity of the afimbrial adhesion-encoding operon (afa) among uropathogenic Escherichia coli isolates. Infect Immun 1988;56:640-8.
21. Arthur M, Johnson CE, Rubin RH, et al. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun 1989;57:303-13.
22. Ikäheimo R, Siitonen A, Kärkkäinen U, Mäkelä PH. Virulence characteristics of Escherichia coli in nosocomial urinary tract infection. Clin Infect Dis 1993;16:785-91.
23. Ikäheimo R, Siitonen A, Kärkkäinen U, Kuosmanen P, Mäkelä PH. Characteristics of Escherichia coli in acute community-acquired cystitis of adult women. Scand J Infect Dis 1993;25:705-12.
24. Siitonen A, Martikainen R, Ikäheimo R, Palmgren J, Mäkelä PH. Virulence-associated characteristics of Escherichia coli in urinary tract infection: a statistical analysis with special attention to type 1C fimbriation. Microb Pathog 1993;15:65-75.
25. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991;4:80-128.
26. Stamm WE. Cystitis and urethritis. In: Schrier RW, Gottschalk CW, eds. Diseases of the kidney. 5th ed. Vol 1. Boston/Toronto: Little, Brown, 1993:1007-27.
27. Svanborg C. Resistance to urinary tract infection. N Engl J Med 1993;329:802-3.
28. Stamey TA, Timothy MM, Millar M. Recurrent urinary tract infections in adult women. The role of introital enterobacteria. California Medicine 1971;1:155.
29. Stamey TA, Sexton CC. The role of vaginal colonization with Enterobacteriaceae in recurrent urinary tract infections. J Urol 1975;113:214.
30. Kunin CM, Polyak F, Postel E. Periurethral bacterial flora in women. Prolonged intermittent colonization with Escherichia coli. JAMA 1980;243:134-9.
31. Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, DC: American Society for Microbiology, 1991.
32. Siitonen A. Escherichia coli in fecal flora of healthy adults: serotypes, P and type 1C fimbriae, non-P mannose-resistant adhesins, and hemolytic activity. J Infect Dis 1992;166:1058-65.
33. Kärkkäinen U, Ikäheimo R, Katila M-L, Mäntyjärvi R. P fimbriation of Escherichia coli strains from patients with urosepsis demonstrated by a commercial agglutination test (PF test). J Clin Microbiol 1991;29:221-4.
34. Pere A, Leinonen M, Väisänen-Rhen V, Rhen M, Korhonen TK. Occurrence of type 1C-fimbriae on Escherichia coli strains isolated from human extraintestinal infections. J Gen Microbiol 1985;131:1705-11.
35. Pere A, Novicki B, Saxén H, Siitonen A, Korhonen TK. Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis 1987;156:567-74.
36. Grimont F, Grimont PAD. Ribosomal ribonucleic acid gene restriction patterns as potential taxonomic tools. Ann Microbiol (Paris) 1986; 137B:165-75.
37. Brosius J, Ullrich A, Raker MA, et al. Construction and fine mapping of recombinant plasmids containing rrnB ribosomal RNA operon of E. coli. Plasmid 1981;6:112-8.
38. Bingen EH, Denamur E, Picard B, et al. Molecular epidemiology unravels the complexity of neonatal Escherichia coli acquisition in twins. J Clin Microbiol 1992;30:1896-8.
39. Tarkka E, Åhman H, Siitonen A. Ribotyping as an epidemiologic tool for Escherichia coli. Epidemiol Infect 1994;112:263-74.
40. Guttmann D. Follow-up of urinary tract infection in domiciliary patients. In: Brumfitt W, Asscher AW, eds. Proceedings of the second national symposium on urinary tract infection (London). Oxford: Oxford University Press, 1973:62-73.
41. Vosti KL. Recurrent urinary tract infections. Prevention by prophylactic antibiotics after sexual intercourse. JAMA 1975;231:934-40.
42. Kraft JK, Stamey TA. The natural history of symptomatic recurrent bacteriuria in women. Medicine (Baltimore) 1977;56:55-60.
43. Stamm WE, McKevitt M, Roberts PL, White NJ. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991;13:77-84.
44. Sourander LB, Kasanen A. A 5-year follow-up of bacteriuria in the aged. Gerontol Clin 1972;14:274-81.
45. Sourander LB. Urinary tract infection in the aged - an epidemiological study. Ann Med Intern Fenn 1966;55(suppl 45):7-55.
46. Dontas AS, Kasviki-Charvati P, Papanayiotou PC, Marketos SG. Bacteriuria and survival in old age. N Engl J Med 1981;304:939-43.
47. Romano JM, Kaye D. UTI in the elderly: common yet atypical. Geriatrics 1981;36:113-20.
48. Sanford JP. Urinary tract symptoms and infections. Annu Rev Med 1975;26:485-98.
49. Foxman B, Frerichs RR. Epidemiology of urinary tract infection: 1. Diaphragm use and sexual intercourse. Am J Public Health 1985;75: 1308-13.
50. Strom BL, Collins M, West SL, Kreisberg J, Weller S. Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriuria. A case control study. Ann Intern Med 1987;107: 816-23.
51. Remis RS, Gurwith MJ, Gurwith D, Hargrett-Bean NT, Layde PM. Risk factors for urinary tract infection. Am J Epidemiol 1987; 126:685-94.
52. Nicolle LE, Harding GKM, Preiksaitis J, Ronald AR. The association of urinary tract infection with sexual intercourse. J Infect Dis 1982; 146:579-83.
53. Leibovici L, Albert G, Laor A, Kalter-Leibovici O, Danon YL. Urinary tract infections and sexual activity in young women. Arch Intern Med 1987;147:345-7.
54. Stapleton A, Moseley S, Stamm WE. Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. J Infect Dis 1991;163:773-9.
55. Tullus K, Kühn I, Orskov I, Orskov F, Möllby R. The importance of P and type 1 fimbriae for the persistence of Escherichia coli in the human gut. Epidemiol Infect 1992;108:415-21.